Advertisement

Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The efficacy of orally administered trimethoprim/sulfamethoxazole for infection prevention following induction chemotherapy was evaluated in 43 patients with acute leukemia. Twenty patients were randomly assigned to treatment with trimethoprim/sulfamethoxazole during 20 episodes of profound granulocytopenia; 23 patients in the control group were followed through 25 granulocytopenic episodes. The incidences of superficial skin and overall infections were significantly tower in those patients with multiple relapses who received trimethoprim/sulfamethoxazole (p = 0.008); however, there was no difference between the groups in regard to days of fever, days of antibiotic administration, days of hospitalization, or gram-negative rod bacteremia. As a result of this study, this regimen cannot be unequivocally recommended for infection prevention in neutropenic patients with acute leukemia undergoing induction or reinduction chemotherapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Armstrong D
        • Young LS
        • Meyer RD
        • Blevins AH
        Infectious complications of neoplastic disease.
        Med Clin North Am. 1971; 55: 729-745
        • Bodey GP
        • Buckley M
        • Sathe YS
        • Freireich EJ
        Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia.
        Ann Intern Med. 1966; 64: 328-340
        • Schimpff SC
        Therapy of infection in patients with granulocytopenia.
        Med Clin North Am. 1974; 61: 1101-1118
        • Chang HY
        • Rodriguez NG
        • Narboni G
        • Bodey GP
        • Luna MA
        • Freireich EJ
        Causes of death in adults with acute leukemia.
        Medicine (Baltimore). 1976; 55: 259-268
        • Bodey GP
        • Loftis J
        • Bormen E
        Protected environments for cancer patients.
        Arch Intern Med. 1968; 122: 22-30
        • Dietrich M
        Reverse isolation and gut decontamination in the management of cancer patients.
        Eur J Cancer. 1979; 15: 45-49
        • Gurwith MJ
        • Brunton JL
        • Lank BA
        • Harding GKM
        • Ronald AR
        A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.
        Am J Med. 1979; 66: 248-256
        • Schimpff SC
        • Greene WH
        • Young VM
        • et al.
        Infection prevention in acute non-lymphocytic leukemia: laminar air flow room reverse isolation with oral nonabsorbable antibiotic prophylaxis.
        Ann Intern Med. 1975; 82: 351-358
        • Weiser B
        • Lange M
        • Fialk MA
        • Singer C
        • Szatrowski TH
        • Armstrong D
        Prophylactic trimethoprlm/sulfamethoxazole during consolidation chemotherapy for acute leukemia, a controlled trial.
        Ann Intern Med. 1981; 95: 436-438
        • Enno A
        • Darrel J
        • Hows J
        • Catovsky D
        • Goldman JM
        • Galton DAG
        Co-trimoxazole for prevention of infection in acute leukemia.
        Lancet. 1978; II: 395-397
        • Dekker AW
        • Rozenberg-Arska M
        • Sixma JJ
        • Verhoeff J
        Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia.
        Ann Intern Med. 1981; 95: 555-559
        • Pizzo PA
        • Robechaud KJ
        • Brenda KE
        • Shumaker C
        • Barrett KS
        Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
        J Pediatr. 1983; 102: 123-125
        • Gaya H
        • Glauser M
        • Klastersky J
        • et al.
        Double-blind placebo controlled trial of prophylactic trimethoprim and sulfamethoxazole (TMP-SMZ) for the prevention of infection in granulocytopenic patients (abstr 331).
        in: Proceedings of the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington1980
        • Wilson JM
        • Gurney DG
        Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia. Isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.
        N Engl J Med. 1982; 306: 16-20